Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Transplant Proc. 2022 Jan-Feb;54(1):135-143. doi: 10.1016/j.transproceed.2021.11.010. Epub 2021 Dec 30.
Pulmonary hypertension (PH) is a known complication of hereditary hemorrhagic telangiectasia (HHT) in patients with hepatic arteriovenous malformations (HAVM). Orthotopic liver transplantation (OLT) is a recognized treatment of HAVM in HHT, but its effect on PH has not been reported in detail before.
Systematic review on HHT patients with pre- or postcapillary PH who underwent OLT and report of a case.
Twenty-one patients were included from 7 articles, all case reports or case series. All had high-output cardiac failure prior to OLT. Two patients had precapillary PH, both related to ALK1 mutations. All patients but 1 showed significant improvement or complete resolution of PH after transplantation. One patient died of acute cardiac failure postoperatively. We also report the case of a 72-year-old woman with type 3 HHT and severe mixed pre- and postcapillary PH. The patient presented with multiple HAVM, left-to-right shunting, and severe but partially reversible combined pre- and postcapillary PH, without ALK1 mutation. After recurrent cholangitis episodes, liver abscesses, and severe obstruction of the right-sided biliary tree, an interdisciplinary decision was taken to proceed with OLT despite PH. Intraoperatively, PH resolved almost instantly after hepatic artery ligation and hepatectomy.
In our patient, OLT completely abrogated mixed pre- and postcapillary PH. Based on this systematic review, we suggest that OLT should be considered a viable treatment option in patients with HHT, HAVM, and mixed pre- and postcapillary PH, featuring cardiac failure and drug responsive PH, rather than being seen as a major risk factor for cardiopulmonary complications.
遗传性出血性毛细血管扩张症(HHT)患者并发肝动静脉畸形(HAVM)可导致肺动脉高压(PH)。原位肝移植(OLT)是治疗 HHT 合并 HAVM 的公认方法,但之前尚未详细报道其对 PH 的影响。
对接受 OLT 治疗且伴有毛细血管前或毛细血管后 PH 的 HHT 患者进行系统评价,并报告 1 例病例。
从 7 篇文献中纳入了 21 例患者,均为病例报告或病例系列。所有患者在 OLT 前均存在高心输出量心力衰竭。2 例患者存在毛细血管前 PH,均与 ALK1 突变相关。所有患者除 1 例外,在移植后 PH 均显著改善或完全缓解。1 例患者术后死于急性心力衰竭。我们还报告了 1 例 72 岁女性的病例,其患有 3 型 HHT 合并严重混合性毛细血管前和毛细血管后 PH。该患者表现为多发性 HAVM、左向右分流以及严重但部分可逆的混合性毛细血管前和毛细血管后 PH,无 ALK1 突变。在反复发作的胆管炎、肝脓肿和右侧胆管严重梗阻后,经多学科讨论决定尽管存在 PH 仍进行 OLT。术中,在结扎肝动脉和肝切除后 PH 几乎立即得到缓解。
在我们的患者中,OLT 完全消除了混合性毛细血管前和毛细血管后 PH。基于该系统评价,我们建议对于 HHT、HAVM 和混合性毛细血管前和毛细血管后 PH 合并心力衰竭和药物反应性 PH 的患者,OLT 应被视为一种可行的治疗选择,而不应被视为心肺并发症的主要危险因素。